Skip to content

A study to evaluate the effects of irradiation by test product on amount of ATP in the body Part2

A study to evaluate the effects of irradiation by test product on amount of ATP in the body Part2 - A study to evaluate the effects of irradiation by test product on amount of ATP in the body Part2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041271
Enrollment
20
Registered
2020-08-01
Start date
2020-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

60 minutes irradiation to the top of head and lower abdomen.

Sponsors

IMEQRD Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 20 to 64 years old 2. Healthy Japanese males and females. 3. Those who take breakfast, lunch and dinner everyday. 4. Those who can provide their written informed consent.

Exclusion criteria

Exclusion criteria: 1.Those who are currently receiving drug treatment of chronic illness. 2.Those who have a current or a past medical history of severe diseases. 3.Those who have a past and current medical history of drug or food allergy. 4.Those who started taking any of the following products in the past three months: drugs, quasi-drug products, and also those who have been routinely taking these products. Those who intend to take these products during the study period. 5.Heavy drinkers. 6.Smoker 7.Those who work night shifts. 8.Those who are currently undergoing treatment for drug dependence or drug abuse or those who have a past medical history of either of them. 9.Those who are currently pregnant or breastfeeding or those who want to become pregnant during the study period. 10.Those who are currently participating in another clinical trial or those who took a test product and completed another clinical trial in a month. 11.Those who were determined by the principal investigator and the sub investigator to be unsuitable for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Adenosine Triphosphate

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026